SCHEMBL21859244

SCHEMBL21859244

CN(C)CC/C=C1/c2ccccc2CCc2cc(Cl)ccc21

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 6/20 0.76
HRH1 P35367 6/20 0.76
SLC6A2 P23975 5/20 0.76
CYP2D6 P10635 5/20 0.76
KCNH2 Q12809 5/20 0.76
CYP1A2 P05177 4/20 0.76
CHRM2 P08172 4/20 0.76
ADRA2A P08913 4/20 0.76
CHRM1 P11229 4/20 0.76
DRD2 P14416 4/20 0.76
SLC6A4 P31645 4/20 0.76
ADRA1A P35348 4/20 0.76
DRD3 P35462 4/20 0.76
NFKB1 P19838 3/20 0.76
SLC22A1 O15245 3/20 0.76
HTR1A P08908 3/20 0.76
DRD1 P21728 3/20 0.76
DRD5 P21918 3/20 0.76
HTR6 P50406 3/20 0.76
MC3R P41968 3/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22073557 1.00 HTR2B (0.76) HTR2BHRH1SLC6A2CYP2D6KCNH2
SCHEMBL22077149 0.92 HRH1 (0.76) HTR2BHRH1SLC6A2CYP2D6KCNH2
Amitriptyline SCHEMBL7824 0.87 SLC6A2 (1.00) HTR2BHRH1SLC6A2CYP2D6KCNH2
Amitriptyline SCHEMBL2877708 0.87 SLC6A2 (1.00) HTR2BHRH1SLC6A2CYP2D6KCNH2
Amitriptyline SCHEMBL29359365 0.87 SLC6A2 (1.00) HTR2BHRH1SLC6A2CYP2D6KCNH2
SCHEMBL9942665 0.87 HTR2B (0.76) HTR2BHRH1SLC6A2CYP2D6KCNH2
SCHEMBL9942664 0.87 HTR2B (0.76) HTR2BHRH1SLC6A2CYP2D6KCNH2
SCHEMBL17727614 0.87 HTR2B (0.76) HTR2BHRH1SLC6A2CYP2D6KCNH2
Amitriptyline SCHEMBL7215255 0.86 SLC6A2 (0.97) HTR2BHRH1SLC6A2CYP2D6KCNH2
Amitriptyline SCHEMBL14937172 0.86 SLC6A2 (1.00) HTR2BHRH1SLC6A2CYP2D6KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020063999-A1 MONO HALOGEN OR METHYL-SUBSTITUTED 5-HT2B ANTAGONISTS WITH INCREASED ACTIVITY NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2020-04-02 WO disclosed